» Articles » PMID: 23033114

Fruit Juices As Perpetrators of Drug Interactions: the Role of Organic Anion-transporting Polypeptides

Overview
Publisher Wiley
Specialty Pharmacology
Date 2012 Oct 4
PMID 23033114
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Grapefruit juice is widely recognized to cause important drug interactions via inhibition of CYP3A4, and a wider variety of fruit juices have been shown to inhibit influx transporters in enterocytes known as organic anion-transporting polypeptides (OATPs). Fruit juice coadministration significantly reduces the oral bioavailability of numerous important medicines relying on this anion transporter pathway for absorption. This article reviews the current literature on interactions between clinically used OATP substrates and fruit juice consumption.

Citing Articles

Editorial: Case reports in hematological malignancies: 2022.

Antar A, Szallasi A, Imataki O Front Oncol. 2023; 13:1272547.

PMID: 37671065 PMC: 10476086. DOI: 10.3389/fonc.2023.1272547.


Interactions between natural products and cancer treatments: underlying mechanisms and clinical importance.

Chan W, Adiwidjaja J, McLachlan A, Boddy A, Harnett J Cancer Chemother Pharmacol. 2023; 91(2):103-119.

PMID: 36707434 PMC: 9905199. DOI: 10.1007/s00280-023-04504-z.


The successful combination of grapefruit juice and venetoclax in an unfit acute myeloid leukemia patient with adverse risk: A case report.

Long Z, Ruan M, Wu W, Zeng Q, Li Q, Huang Z Front Oncol. 2022; 12:912696.

PMID: 36248996 PMC: 9554551. DOI: 10.3389/fonc.2022.912696.


The involvement of human organic anion transporting polypeptides (OATPs) in drug-herb/food interactions.

Ali Y, Shams T, Wang K, Cheng Z, Li Y, Shu W Chin Med. 2020; 15:71.

PMID: 32670395 PMC: 7346646. DOI: 10.1186/s13020-020-00351-9.


Potential Risk of Food-Drug Interactions: Citrus Polymethoxyflavones and Flavanones as Inhibitors of the Organic Anion Transporting Polypeptides (OATP) 1B1, 1B3, and 2B1.

Bajraktari-Sylejmani G, Weiss J Eur J Drug Metab Pharmacokinet. 2020; 45(6):809-815.

PMID: 32661908 PMC: 7677148. DOI: 10.1007/s13318-020-00634-4.